亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

萊佛士制藥技術有限公司  

醫藥中間體和原料藥;有機催化劑;提供國際水準的綠色工藝開發、定制合成與生產等方面的服務

搜索
新聞中心
  • 暫無新聞
產品分類
聯系方式
  • 聯系人:莫先生
  • 電話:0752-5538396
  • QQ:2634038916
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 376592-93-7
376592-93-7
單價 面議對比
詢價 暫無
發貨 廣東惠州市付款后3天內
品牌 RAFFLES
規格 1-10g;100g;500g;1kg;10kg
純度 ≥98%
貨期 1-2 周
過期 長期有效
更新 2016-08-15 10:26
 
詳細信息
 
中文名稱: 3'-氨基-2'-羥基-[1,1'-聯苯]-3-甲酸
中文同義詞: 3'-氨基-2'-羥基-[1,1'-聯苯]-3-甲酸;伊屈潑帕中間體2;EBP氨基物中間體;3'-氨基-2'-羥基聯苯-3-羧酸;3'-氨基-2'-羥基聯苯基-3-甲酸
英文名稱: 3''-AMINO-2''-HYDROXY-BIPHENYL-3-CARBOXYLIC ACID
英文同義詞: 3''-AMINO-2''-HYDROXY-BIPHENYL-3-CARBOXYLIC ACID;3'-Amino-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid;Eltrombopag Intermediate 2;EltroMbopag I;3-(3-aMino-2-hydroxyphenyl)benzoic acid;[1,1'-Biphenyl]-3-carboxylic acid, 3'-aMino-2'-hydroxy-;3''-AMINO-2''-HYDROXY-BIPHENYL-3-CARBOXYLIC
CAS號: 376592-93-7
分子式: C13H11NO3
分子量: 229.234
EINECS號:  
相關類別: 原料藥中間體;催化劑;醫藥中間體
Mol文件: 376592-93-7.mol
3'-氨基-2'-羥基-[1,1'-聯苯]-3-甲酸
©2025 萊佛士制藥技術有限公司 版權所有   技術支持:化工網   訪問量:2806  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |